Target intelligence / Profile preview

Secreted sticky lipoprotein (SslE) (SslE)

Target
SslE
Molecular classification
Enzyme, Metalloprotease, Lipoprotein, Hydrolase
01

Overview

Secreted sticky lipoprotein (SslE), historically referred to as YghJ, is a highly conserved surface-exposed lipoprotein and zinc-metallopeptidase secreted by various pathogenic strains of Escherichia coli, including Enterotoxigenic (ETEC) and Extraintestinal pathogenic E. coli (ExPEC) [1, 2]. It serves as a critical virulence factor by functioning as a mucinase that degrades major human intestinal mucins, such as MUC2 and MUC3, thereby facilitating bacterial transit through the protective mucus barrier to reach the underlying host epithelium [3, 4]. Beyond its enzymatic role, SslE contributes to bacterial aggregation and biofilm formation, which are essential for stable colonization and persistence within the host environment [2, 5]. Due to its broad conservation across diverse E. coli pathotypes and its accessibility on the bacterial surface, SslE is a primary target for the development of broad-spectrum vaccines and therapeutic antibodies [1, 6]. Experimental studies have demonstrated that antibodies targeting SslE can neutralize its mucinase activity and significantly reduce bacterial colonization in vivo, making it a promising candidate for preventing both enteric and extraintestinal infections [5, 6]. [1] UniProt Consortium, P0ADK8; [2] Moriel et al. (2010) PNAS; [3] Luo et al. (2014) Infection and Immunity; [4] Fleckenstein et al. (2014) Microbes and Infection; [5] Nesta et al. (2014) PLOS Pathogens; [6] Valeri et al. (2015) EMBO Reports.

Other names
YghJMucin-degrading metalloprotease YghJECOPEscherichia coli opportunistic pathogen protein
02

Mechanism of action

Neutralization of mucinase activity to prevent bacterial penetration of the host mucus layer and subsequent attachment to epithelial cells.

03

Biological functions

ProteolysisMucin degradationBacterial colonizationBiofilm formationBacterial adhesion
04

Disease associations

InfectionDiarrheaUrinary tract infectionSepsisNeonatal meningitis
05

Safety considerations

Immunogenicity variability across different populationsPotential for bacterial antigenic drift or escape mutantsTheoretical cross-reactivity with host metalloproteases (though low risk due to structural divergence)
06

Interacting drugs

ETVAX (investigational vaccine)

1 more in the full profile.

07

Biomarkers

Anti-SslE IgG antibody titersAnti-SslE IgA antibody titersPresence of sslE gene in clinical isolates

Beyond the preview

Go deeper on Secreted sticky lipoprotein (SslE) (SslE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secreted sticky lipoprotein (SslE) (SslE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call